News for 'pharmaceuticals'

What India gives, and what it gets: Highlights of India-US interim trade deal

What India gives, and what it gets: Highlights of India-US interim trade deal

Rediff.com7 Feb 2026

Both countries commit to provide each other preferential market access in sectors of respective interest on a sustained basis

India cosponsors UN resolution condemning Iran's attacks on Gulf countries

India cosponsors UN resolution condemning Iran's attacks on Gulf countries

Rediff.com12 Mar 2026

The UN Security Council, with India's support, has adopted a resolution condemning Iran's attacks on Gulf Cooperation Council countries and Jordan, demanding an immediate cessation of hostilities and denouncing threats to the Strait of Hormuz.

Iran Rewrites Rules of War

Iran Rewrites Rules of War

Rediff.com17 Mar 2026

Iran is fighting a different war: Older, slower, and in some ways more dangerous. Iran doesn't need to shoot down an F/A-18. It only needs to make the Strait of Hormuz feel dangerous long enough for insurance markets, shipping companies, and oil futures traders to do the rest. Prem Panicker continues his must-read daily blog on the war in the Middle East.

Sensex closed 283 points higher on buying in bank, metal shares

Sensex closed 283 points higher on buying in bank, metal shares

Rediff.com18 Feb 2026

Benchmark equity indices Sensex and Nifty extended their gains for the third straight session on Wednesday, driven by last-hour buying in bank, metal, and FMCG shares.

New launches to keep growth momentum healthy for Sun Pharma stock

New launches to keep growth momentum healthy for Sun Pharma stock

Rediff.com13 Feb 2026

A strong third-quarter (October-December/Q3) performance for 2025-26 (FY26) has helped the stock of India's largest listed pharmaceutical (pharma) company, Sun Pharmaceutical Industries, gain about 7 per cent since the start of February.

Stock Market Today: Sensex, Nifty50 React to Global Cues and Trump Tariff Concerns

Stock Market Today: Sensex, Nifty50 React to Global Cues and Trump Tariff Concerns

Rediff.com24 Feb 2026

Indian equities on Dalal Street saw volatility as global market trends and fresh tariff concerns linked to Donald Trump impacted investor sentiment. Track Sensex, Nifty50 movement and key market drivers for Feb 24, 2026.

Sensex Plunges 1069 Points on IT Selloff, Global Trade Worries

Sensex Plunges 1069 Points on IT Selloff, Global Trade Worries

Rediff.com24 Feb 2026

Equity benchmark indices Sensex and Nifty experienced a significant decline, primarily driven by a selloff in IT stocks due to concerns about AI disruption and renewed worries over global trade.

From 18% to 10%: Trump's new global levy brings relief for India

From 18% to 10%: Trump's new global levy brings relief for India

Rediff.com21 Feb 2026

US President Donald Trump announced a new global levy on imported items, resulting in a lower tariff rate for India, following a Supreme Court verdict against his previous sweeping tariffs.

Blow to Trump as US Supreme Court strikes down his sweeping tariffs

Blow to Trump as US Supreme Court strikes down his sweeping tariffs

Rediff.com20 Feb 2026

The verdict marks a notable shift from a series of recent wins for Trump at the Supreme Court.

Healthcare Funds: Caution Advised

Healthcare Funds: Caution Advised

Rediff.com12 Feb 2026

Most first-time investors may be better served by diversified options such as flexicap or multi-cap funds, which already hold pharma and healthcare stocks.

Trump's tariff junked: What it means for Indian companies

Trump's tariff junked: What it means for Indian companies

Rediff.com21 Feb 2026

India will now face a lower reciprocal tariff of 10 per cent, down from 25 per cent, after US President Donald Trump announced a new global levy on items imported into America in the wake of the Supreme Court verdict against his sweeping duties on several nations.

India-EU FTA: Textiles, pharma, engineering to get major boost

India-EU FTA: Textiles, pharma, engineering to get major boost

Rediff.com26 Jan 2026

Textiles, pharmaceuticals, chemicals, engineering goods, gems and jewellery exports will receive a boost from the free trade agreement between India and the 27-nation European Union, according to exporters.

Will MBA In Dubai Earn Over Rs 18 LPA?

Will MBA In Dubai Earn Over Rs 18 LPA?

Rediff.com4 Feb 2026

rediffGURU Patrick D'souza, CAT expert and founder of Patrick100 explains how to pick a management course and college that will boost your career.

Sensex gains 398 points on easing of geopolitical tensions

Sensex gains 398 points on easing of geopolitical tensions

Rediff.com22 Jan 2026

Benchmark equity indices Sensex and Nifty rebounded on Thursday after three sessions of losses, tracking gains in global markets after US President Donald Trump struck a conciliatory tone on Greenland. In a volatile session, the 30-share BSE Sensex climbed 397.74 points, or 0.49 per cent, to close at 82,307.37.

Tariffs cut, $30tn market: India, US unveil interim trade pact

Tariffs cut, $30tn market: India, US unveil interim trade pact

Rediff.com8 Feb 2026

The agreement addresses non-tariff barriers and promotes increased trade in technology products and cooperation between the two countries.

Trump raises global tariff from 10% to 15% day after SC ruling

Trump raises global tariff from 10% to 15% day after SC ruling

Rediff.com21 Feb 2026

Following a Supreme Court setback, Donald Trump has announced an increase in global tariffs from 10% to 15%, impacting international trade relations and raising concerns about economic repercussions.

Sensex, Nifty close almost unchanged in choppy trade

Sensex, Nifty close almost unchanged in choppy trade

Rediff.com11 Feb 2026

Benchmark stock indices Sensex and Nifty closed on a flat note in a choppy session on Wednesday as gains in PSU banks and auto shares were offset by losses in IT stocks.

Supreme Court's ruling on tariffs is deeply disappointing: Trump

Supreme Court's ruling on tariffs is deeply disappointing: Trump

Rediff.com21 Feb 2026

The ruling is expected to have wide-ranging consequences for global trade, businesses, consumers, inflation trends and household finances across the country.

Sensex reclaims 84K-mark; Nifty ends up 174 points

Sensex reclaims 84K-mark; Nifty ends up 174 points

Rediff.com9 Feb 2026

Benchmark equity indices Sensex and Nifty extended their gains for the second straight session on Monday, driven by optimism over the India-US trade deal and robust buying in public sector banks, consumer durables, and realty stocks.

73% employers plan to hire freshers in H1 2026

73% employers plan to hire freshers in H1 2026

Rediff.com18 Feb 2026

Around 73 per cent of employers interviewed intend to hire freshers during January-June 2026, with recruitment decisions mainly driven by internships and real-world project experience rather than academic credentials alone, a report said on Wednesday. Nearly 3 in 4 employers (73 per cent) intend to hire freshers during January-June this year, marking a 3 per cent increase over the previous half-year, according to TeamLease EdTech Career Outlook Report HY1 2026.

Sensex up 174 points on gains in bank, IT stocks

Sensex up 174 points on gains in bank, IT stocks

Rediff.com17 Feb 2026

Stock markets closed higher for the second straight session on Tuesday, driven by gains in bank, IT and capital goods shares.

10 WORST Ingredients For Skin and Hair

10 WORST Ingredients For Skin and Hair

Rediff.com16 Feb 2026

Though some ingredients such as mild odours or silicones might not be actually harmful, others such as sulphates, parabens or formaldehyde releasers can result in skin irritation, hormonal imbalances and skin barrier damage, advises Dr Ameesha Mahajan.

Must Watch Movies And Shows On OTT

Must Watch Movies And Shows On OTT

Rediff.com23 Feb 2026

Discover the latest OTT releases, streaming between February 23 and March 1.

Hyderabad claims its place as global MNC destination

Hyderabad claims its place as global MNC destination

Rediff.com18 Feb 2026

Hyderabad is rapidly emerging as a strategic hub for multinational companies (MNCs) deepening their focus on artificial intelligence (AI), life sciences, and global capability centres (GCCs), supported by the city's strong pharmaceutical (pharma) base, deeptech talent pool, and a policy environment that encourages high-value investment.

Ficci manufacturing index at all-time high in Q3

Ficci manufacturing index at all-time high in Q3

Rediff.com21 Jan 2026

The quarterly manufacturing index by the industry body Federation of Indian Chambers of Commerce & Industry (Ficci) rose to an all-time high in the third quarter of financial year 2025-26 (Q3FY26), with 91 per cent of respondents reporting either higher or same production levels, against 87 per cent in the previous quarter.

Exports rise 1.87% in December 2025; trade deficit widens marginally

Exports rise 1.87% in December 2025; trade deficit widens marginally

Rediff.com15 Jan 2026

The country's exports rose 1.87 per cent to $38.5 billion in December 2025 despite global economic uncertainties, though an increase in imports led to a marginal widening of the trade deficit to $25 billion.

Emcure sets sights on pan-Indian obesity market with Poviztra

Emcure sets sights on pan-Indian obesity market with Poviztra

Rediff.com23 Dec 2025

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.

Sensex surged 2,073 points at close, Nifty ended at 25,728

Sensex surged 2,073 points at close, Nifty ended at 25,728

Rediff.com3 Feb 2026

Stock market benchmark indices Sensex and Nifty ended 2.5 per cent higher on Tuesday after India and the US agreed to a trade deal under which Washington will bring down the reciprocal tariff on Indian goods to 18 per cent.

Gold, Silver Surge Pushes Jan Import Bill Up

Gold, Silver Surge Pushes Jan Import Bill Up

Rediff.com19 Feb 2026

Gold imports climbed 349.22 per cent to $12.07 billion in January, while silver imports rose 127 per cent to $2 billion.

Equity Markets' Challenges: Weak Demand, High Valuation

Equity Markets' Challenges: Weak Demand, High Valuation

Rediff.com17 Feb 2026

Trade deals ease risks for Indian equities, but weak demand and stretched valuations raise questions over whether optimism -- especially in smallcaps -- can turn into a sustained bull run, points out Debashis Basu.

New Zealand opens longer work visas for Indian students

New Zealand opens longer work visas for Indian students

Rediff.com22 Dec 2025

New Zealand has liberalised mobility provisions under the concluded trade pact, enabling Indian students to access longer post-study work visas and allowing 5,000 Indian professionals, including yoga instructors and chefs, to work in the Oceania country.

Budget 2026 boosts healthcare spend, drugs relief

Budget 2026 boosts healthcare spend, drugs relief

Rediff.com1 Feb 2026

The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, including those aimed at making India a global hub for allied healthcare professionals and biopharma manufacturing.

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Indian pharma companies see sharp drop in adverse USFDA findings in 2025

Rediff.com8 Jan 2026

The US Food and Drug Administration (USFDA) recorded a significant decline in serious regulatory findings at Indian drug manufacturing facilities between January and December 2025. Data reveals that 'official action indicated' (OAI) cases - the most severe classification - nearly halved over the past year.

'Equity Market Poised For Comeback In 2026'

'Equity Market Poised For Comeback In 2026'

Rediff.com14 Jan 2026

'The bigger unknown remains global geopolitics, which is inherently unpredictable, including developments in our neighbourhood.' 'Another concern is the increasing tilt of government finances towards welfare subsidies, especially at the state level.' 'This could constrain capital expenditure, which is critical for long-term growth.'

Rare-Disease, Cancer Drugs Get Cheaper

Rare-Disease, Cancer Drugs Get Cheaper

Rediff.com3 Feb 2026

For patients, the immediate impact is a reduction in the final cost of therapies that often run into lakhs per month.

Kerala: First State To Have State 'Bacteria'

Kerala: First State To Have State 'Bacteria'

Rediff.com29 Jan 2026

'We have tags of state animals and birds. However, the invisible world of microbes is doing a lot of things for us in nature, not just for human beings but for the entire life.'

Hungry IPOs Carve A Heft Slice Of Mutual Funds

Hungry IPOs Carve A Heft Slice Of Mutual Funds

Rediff.com22 Dec 2025

In November, six primary market issuances accounted for more than 13,000 crore of net equity investments by MFs.

No Of Companies That Exited Sensex In 40 Years...

No Of Companies That Exited Sensex In 40 Years...

Rediff.com12 Jan 2026

There were 18 exits from the index between 1995 and 2000. The pace has since dropped to single-digit exits over every five-year period.

Open offers highest since 2008 as acquisition, takeover attempts surge

Open offers highest since 2008 as acquisition, takeover attempts surge

Rediff.com29 Dec 2025

Open offers this calendar year, following attempts at acquisition and takeover, came in at more than two a week. There were 121 such open offers to acquire additional shares following a substantial acquisition or change of control, shows the data compiled by primedatabase.com.

Sigachi Industries CEO held over Telangana plant blast

Sigachi Industries CEO held over Telangana plant blast

Rediff.com28 Dec 2025

A top executive of Sigachi Industries has been arrested in connection with the explosion at its pharma plant in Telangana in June, which resulted in 54 deaths.